Radujkovic, A., Boch, T., Nolte, F., Nowak, D., Kunz, C., Gieffers, A., . . . Luft, T. (2020). Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine Profile. Cancers (Basel).
シカゴスタイル引用形Radujkovic, Aleksandar, et al. "Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined By a Pro-Inflammatory Serum Cytokine Profile." Cancers (Basel) 2020.
MLA引用形式Radujkovic, Aleksandar, et al. "Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined By a Pro-Inflammatory Serum Cytokine Profile." Cancers (Basel) 2020.
警告: この引用は必ずしも正確ではありません.